Recombinant Anti-Human aplha beta TCR Antibody (Non-glycosylated) (CAT#: Gly-181LC)

This product is a non-glycosylated humanized monoclonal antibody. The glycoengineered antibody with removed FcyR binding ability specifically binds to apTCR and can be potentially used in the treatment of T cell mediated diseases.

Specific Inquiry
  • Size:

  • Conjugation:

  • Endotoxin:

  • Purity:

  • Datasheet
  • MSDS
  • COA

Glyco-engineering

  • Activity
  • Removed FcyR binding

Specifications

  • Target
  • aplha beta TCR
  • Host Species
  • Human
  • Derivation
  • Humanized
  • Type
  • Humanized antibody
  • Specificity
  • Human
  • Antibody Isotype
  • IgG1
  • Clone
  • BMA031_HuIgG1
  • Applications
  • ELISA

Target

  • Alternative Names
  • aplha beta TCR
  • Related Disease
  • T cell mediated diseases

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

Customer Reviews and Q&As

Submit a review or a question

There are currently no Customer reviews or questions for Gly-181LC. Click the button above to contact us or submit your feedback about this product.

Popular products with customers


For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare